Universal Brain Announces Publication of Groundbreaking Depression Research Using Multiple Event-Related Potentials 
Ivenix, Inc. Names Jorgen B. Hansen as Chief Executive Officer
Medical device and healthcare industry leader joins Ivenix to lead smart infusion pump commercialization BOSTON--(BUSINESS WIRE)--Ivenix, Inc. today announced the...
University of Chicago Offers Mammosphere from Life Image to Support WISDOM Study Participants, Improve Breast Health Research
Top academic medical center to leverage leading breast health data tool to improve breast screening protocols for groundbreaking study BOSTON--(BUSINESS...
Arcutis Announces Exercise of Option for Exclusive License to Highly Selective JAK1 Inhibitor for All Topical Dermatological Uses in U.S., Canada, Europe and Japan
ARQ-252 potential to offer "Best in Class" topical JAK therapy Phase 2b study in adult patients with hand eczema anticipated...
StageZero Life Sciences Retains Fig House Communications to Manage Investor Relations Activities
TORONTO, ON / ACCESSWIRE / January 13, 2020 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") today announced...
Cannabis Companies Can Boost Value by Utilizing Novus’ Business Model
Novus Named Once Again as Top 30 Stocks by InvestorPlace Magazine MIAMI, FL / ACCESSWIRE / January 13, 2020 / Novus...
Global Resource Energy, Inc. to move forward with Name Change
FORT WORTH, TX / ACCESSWIRE / January 13, 2020 / Global Resource Energy, Inc. (OTC PINK:GBEN) is pleased to announce...
InnoCan Announces Successful Research Study Advancing Its Development of Cannabidiol Targeted Injection Delivery Platform
CALGARY, ALBERTA and TEL AVIV, ISRAEL / ACCESSWIRE / January 13, 2020 / InnoCan Pharma Corporation ("InnoCan" or the "Company")...
MobileSmith Health and AT&T Work Together to Help Hospitals Reduce Cancellations and Complications Across Episodes of Care
Peri™ integration supports pre- and post-procedural adherence, reduces costs and improves overall health outcomes RALEIGH, NC / ACCESSWIRE / January...
Aptevo Therapeutics’ APVO436 Selected For Inclusion In The Leukemia & Lymphoma Society’s Groundbreaking BEAT AML(R) Master Clinical Trial
APVO436 is the Latest Investigational AML Therapeutic to be Selected for Participation in the Study; Aptevo Joins Industry Leaders, Bristol-Myers...
Announcing the Launch of Our Newly Redesigned Citizen Stash Website
VANCOUVER, BC / ACCESSWIRE / January 13, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to...
Northwell Health Extends Allscripts® Managed Services Agreement Through 2026
CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced that Northwell Health, New York State’s largest health system, has extended its...
Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2019 Revenue Results
– Q4 2019 Total Preliminary Revenue of $78.4 to $79.4 million – – Updates 2020 Guidance – GOLETA, Calif.--(BUSINESS WIRE)--Inogen,...
STAAR Surgical Reports Preliminary Fourth Quarter Net Sales Growth of 25%
Achieves 33% ICL Unit Growth for Fiscal 2019 Provides Initial Outlook for Fiscal 2020 LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company...
Sphingotec Launches IVD Test for Kidney Function Biomarker penKid(R) on Nexus IB10 POCT Platform
sphingotec launches a CE-marked point-of-care IVD assay for Proenkephalin (penKid(R)), the company's proprietary biomarker for real-time assessment of kidney function...
MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab
- MorphoSys and Incyte to co-commercialize tafasitamab in the U.S. - Incyte has exclusive commercialization rights outside of the U.S....
MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / January 13, 2020 / MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:...
Flow Pharma, Inc. Presenting Mouse Breast Cancer Study Data
Flow Pharma CEO, Reid Rubsamen, M.D. will be presenting an update on the company's pre-clinical and clinical breast cancer studies...
Great Bay Bio injected with 2.5 million USD of convertible note
HONG KONG, CHINA / ACCESSWIRE / January 12, 2020 / Recently, Great Bay Bio signed off convertible note, and the...
Hologic Announces Preliminary Financial Results for First Quarter of Fiscal 2020
-- Revenue of $850.5 Million Grows 2.4%, 2.8% in Constant Currency -- -- Excluding Acquisitions and Divestitures, Revenue Increases 4.1%,...
CORRECTING and REPLACING REVIAN® Inc. Announces Issuance of Landmark Patent Covering the Use of Light to Stimulate the Body to Heal Itself
Leads to first all-LED medical device that regenerates hair. No chemicals. No pills. Just light. DURHAM, N.C.--(BUSINESS WIRE)--The patent number...